verapamil has been researched along with Erectile Dysfunction in 17 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Erectile Dysfunction: The inability in the male to have a PENILE ERECTION due to psychological or organ dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To describe a patient with an incidental pituitary lesion who experienced verapamil-induced hyperprolactinemia." | 7.69 | Verapamil-induced hyperprolactinemia complicated by a pituitary incidentaloma. ( Aron, DC; Dombrowski, RC; Romeo, JH, 1995) |
| "To evaluate the effects of the transdermal electromotive administration of verapamil and dexamethasone on plaque size, penile deviation, pain, erectile function and capacity for vaginal penetration in patients with Peyronie's disease." | 3.72 | Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. ( Capelli, G; Di Stasi, SM; Giannantoni, A; Jannini, EA; Storti, L; Vespasiani, G; Virgili, G, 2003) |
| "To describe a patient with an incidental pituitary lesion who experienced verapamil-induced hyperprolactinemia." | 3.69 | Verapamil-induced hyperprolactinemia complicated by a pituitary incidentaloma. ( Aron, DC; Dombrowski, RC; Romeo, JH, 1995) |
| "Peyronie's disease is a condition that results in the development of penile plaques that can lead to penile curvature, pain, and erectile dysfunction, making sexual activity difficult." | 3.01 | Non-surgical therapies for Peyronie's disease. ( Blair, Y; Dahm, P; Edwards, ME; Ergun, O; Hwang, EC; Jung, JH; Risk, MC; Rosenberg, JE, 2023) |
| "Both drugs are used to treat hypertension, but only verapamil can be used to produce atrioventricular block in patients with atrial fibrillation." | 2.43 | Mechanism of tissue-selective drug action in the cardiovascular system. ( Barrett, TD; Maurice, DH; Triggle, DJ; Walker, MJ, 2005) |
| "Two cases of cluster headaches triggered by sildenafil are described." | 1.33 | Sildenafil can trigger cluster headaches. ( Evans, RW, 2006) |
| "Scarring was documented in one patient." | 1.29 | Intracavernous self-injection of papaverine and verapamil: a clinical experience. ( Bolayir, K; Gökşin, N, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Rosenberg, JE | 1 |
| Ergun, O | 1 |
| Hwang, EC | 1 |
| Risk, MC | 1 |
| Jung, JH | 1 |
| Edwards, ME | 1 |
| Blair, Y | 1 |
| Dahm, P | 1 |
| Alizadeh, M | 1 |
| Karimi, F | 1 |
| Fallah, MR | 1 |
| Beley, S | 1 |
| Brock, G | 1 |
| Paulis, G | 1 |
| Cavallini, G | 1 |
| Brancato, T | 1 |
| Alvaro, R | 1 |
| Bertolucci, A | 1 |
| Latkany, RA | 1 |
| Gentile, RC | 1 |
| Rosen, RB | 1 |
| Di Stasi, SM | 1 |
| Giannantoni, A | 1 |
| Capelli, G | 1 |
| Jannini, EA | 1 |
| Virgili, G | 1 |
| Storti, L | 1 |
| Vespasiani, G | 1 |
| Barrett, TD | 1 |
| Triggle, DJ | 1 |
| Walker, MJ | 1 |
| Maurice, DH | 1 |
| Ohebshalom, M | 1 |
| Mulhall, JP | 1 |
| Evans, RW | 1 |
| King, BD | 1 |
| Pitchon, R | 1 |
| Stern, EH | 1 |
| Schweitzer, P | 1 |
| Schneider, RR | 1 |
| Weiner, I | 1 |
| Bolayir, K | 1 |
| Gökşin, N | 1 |
| Dombrowski, RC | 1 |
| Romeo, JH | 1 |
| Aron, DC | 1 |
| Mirone, V | 1 |
| Imbimbo, C | 1 |
| Palmieri, A | 1 |
| Fusco, F | 1 |
| Sahin, M | 1 |
| Başar, MM | 1 |
| Bozdoğan, O | 1 |
| Atan, A | 1 |
| Fogelman, J | 2 |
3 reviews available for verapamil and Erectile Dysfunction
| Article | Year |
|---|---|
Non-surgical therapies for Peyronie's disease.
Topics: Erectile Dysfunction; Humans; Male; Pain; Penile Induration; Quality of Life; Randomized Controlled | 2023 |
Mechanism of tissue-selective drug action in the cardiovascular system.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Binding Sites; Calcium Channels; Cardiovascular System; Chemist | 2005 |
Transdermal and topical pharmacotherapy for male sexual dysfunction.
Topics: Administration, Cutaneous; Administration, Topical; Alprostadil; Androgens; Animals; Erectile Dysfun | 2005 |
3 trials available for verapamil and Erectile Dysfunction
| Article | Year |
|---|---|
Evaluation of verapamil efficacy in Peyronie's disease comparing with pentoxifylline.
Topics: Adult; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Iran; Male; Middle Aged; Pain; | 2014 |
Peironimev-Plus® in the treatment of chronic inflammation of tunica albuginea (Peyronie's disease). results of a controlled study.
Topics: 4-Aminobenzoic Acid; Adult; Aged; Anthocyanins; Antioxidants; Biological Therapy; Chronic Disease; D | 2013 |
Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica.
Topics: Adult; Combined Modality Therapy; Erectile Dysfunction; High-Energy Shock Waves; Humans; Male; Middl | 1999 |
11 other studies available for verapamil and Erectile Dysfunction
| Article | Year |
|---|---|
[La Peyronie disease, erectile dysfunction, kidney tumors]].
Topics: Adult; Age Factors; Anti-Inflammatory Agents; Biopsy; Erectile Dysfunction; Follow-Up Studies; Human | 2008 |
Clinical case: 45-year-old male with penile pain (CME).
Topics: Anthropometry; Cicatrix; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Induration; Phospho | 2009 |
Hemi-retinal artery occlusion associated with sexual activity and sildenafil citrate (Viagra).
Topics: Calcium Channel Blockers; Coitus; Erectile Dysfunction; Humans; Hypertension; Male; Middle Aged; Pho | 2003 |
Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease.
Topics: Administration, Cutaneous; Adult; Aged; Dexamethasone; Drug Combinations; Erectile Dysfunction; Huma | 2003 |
Sildenafil can trigger cluster headaches.
Topics: Adult; Calcium Channel Blockers; Cluster Headache; Erectile Dysfunction; Humans; Male; Middle Aged; | 2006 |
Impotence during therapy with verapamil.
Topics: Adult; Aged; Digoxin; Drug Therapy, Combination; Erectile Dysfunction; Heart Diseases; Humans; Male; | 1983 |
Intracavernous self-injection of papaverine and verapamil: a clinical experience.
Topics: Adult; Aged; Cicatrix; Drug Combinations; Erectile Dysfunction; Hematoma; Humans; Injections; Male; | 1994 |
Verapamil-induced hyperprolactinemia complicated by a pituitary incidentaloma.
Topics: Aged; Calcium Channel Blockers; Erectile Dysfunction; Humans; Hyperprolactinemia; Magnetic Resonance | 1995 |
Short-term histopathologic effects of different intracavernosal agents on corpus cavernosum and antifibrotic activity of intracavernosal verapamil: an experimental study.
Topics: Alprostadil; Animals; Calcium Channel Blockers; Chemical and Drug Induced Liver Injury; Disease Mode | 2001 |
Verapamil caused depression, confusion, and impotence.
Topics: Cognition Disorders; Confusion; Depressive Disorder; Erectile Dysfunction; Female; Humans; Hypertens | 1988 |
Verapamil may cause depression, confusion, and impotence.
Topics: Cognition Disorders; Confusion; Depression; Erectile Dysfunction; Humans; Male; Middle Aged; Verapam | 1987 |